GlassScriptPhysician profile
Bryan Barksdale
NPI 1083663876
$8,477.37
in general payments reported to CMS, 2019-2025
32 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,120 · 2020: $615 · 2021: $1,405 · 2022: $1,238 · 2023: $1,155 · 2024: $849 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,099.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,175.95 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $825.51 | 2019-2024 | Andexxa, Wainua, Farxiga |
| Pfizer INC. | $822.51 | 2019-2025 | |
| Abiomed | $716.10 | 2019-2024 | Impella |
| Janssen Pharmaceuticals, INC | $540.68 | 2019-2022 | |
| Boston Scientific Corporation | $473.34 | 2023-2025 | Watchman Access System, Latitude Communicator Power Supply, Mylux Patient Kit With Mobile Device |
| Amgen INC. | $387.99 | 2019-2023 | Repatha |
| Irhythm Technologies, INC. | $330.89 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $291.37 | 2021-2023 | Verquvo |
| Abbott Laboratories | $279.91 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $253.31 | 2021-2025 | Visions 014 |
| Penumbra, INC. | $229.14 | 2022-2025 | Indigo System |
| Novo Nordisk INC | $219.86 | 2024-2025 | Wegovy |
| Akcea Therapeutics, INC. | $199.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $162.66 | 2019-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $149.45 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $139.28 | 2019-2025 | Evkeeza |
| Inspire Medical Systems, INC. | $132.41 | 2025 | Inspire |
| Lantheus Medical Imaging, INC. | $130.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.63 | 2022-2023 | |
| Chiesi USA, INC. | $125.11 | 2024-2025 | Kengreal, Juxtapid |
| Inari Medical, INC. | $121.42 | 2022 | |
| Heartflow, INC. | $120.77 | 2024 | |
| Sanofi-Aventis U.S. LLC | $117.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $113.93 | 2019-2022 | |
| Btg International INC. | $100.80 | 2019 | |
| Scpharmaceuticals INC. | $92.39 | 2023 | |
| Bridgebio Pharma, INC. | $25.02 | 2025 | Attruby |
| Astellas Pharma US INC | $24.23 | 2019 | |
| Lundbeck LLC | $20.01 | 2019 | |
| Mylan Specialty L.P. | $17.41 | 2022 | |
| Ge Healthcare | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Barksdale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.